We came across a bullish thesis on Harmony Biosciences Holdings, Inc. on In. Specter’s Substack. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc.’s share was trading at $34.40 as of August 1st. HRMY’s trailing and forward P/E were 13.13 and 9.29, respectively, according to Yahoo Finance.
A close-up of a pharmaceutical drug bottle, showcasing the potential of the company’s innovative therapies.
Harmony Biosciences Holdings, Inc. (HRMY)...
